AUTOIMMUNITY REVIEWS, vol.11, no.5, pp.330-334, 2012 (SCI-Expanded)
Background and aim: The aim of the present study was to assess the efficacy and tolerability of budesonide as an alternative first line treatment option for autoimmune hepatitis (AIH) and the overlap syndrome.